Laddar...
Cannabinoid CB(2) receptor ligand profiling reveals biased signalling and off-target activity
The cannabinoid CB(2) receptor (CB(2)R) represents a promising therapeutic target for various forms of tissue injury and inflammatory diseases. Although numerous compounds have been developed and widely used to target CB(2)R, their selectivity, molecular mode of action and pharmacokinetic properties...
Sparad:
I publikationen: | Nat Commun |
---|---|
Huvudupphovsmän: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Materialtyp: | Artigo |
Språk: | Inglês |
Publicerad: |
Nature Publishing Group
2017
|
Ämnen: | |
Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5216056/ https://ncbi.nlm.nih.gov/pubmed/28045021 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ncomms13958 |
Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|